Tillkännagivande • Mar 14
BYND Cannasoft Enterprises Receives Approval for Voluntary Delisting of its Common Shares from CSE BYND Cannasoft Enterprises Inc. announced that it has applied and received approval for a voluntary delisting of its common shares from the Canadian Securities Exchange ("CSE"). The delisting from the CSE will not affect the Company's listing on the NASDAQ Capital Market (the "NASDAQ"). The common shares will continue to trade on the NASDAQ under the symbol "BCAN". The Company believes that the trading volume of its shares on the CSE no longer justifies the expenses and administrative efforts required to maintain a dual listing. The Company also believes that delisting from the CSE will create a central marketplace for its common shares on the NASDAQ, and ultimately benefit the long-term liquidity and shareholder value of the Company. It is anticipated that, effective as at the close of trading on or about March 14, 2024, BYND Cannasoft's common shares will no longer be listed and posted for trading on the CSE. Following delisting from the CSE, BYND Cannasoft's shareholders can trade their common shares through their brokers on NASDAQ. Tillkännagivande • Mar 13
BYND Cannasoft Enterprises Inc. has completed a Composite Units Offering in the amount of $7 million. BYND Cannasoft Enterprises Inc. has completed a Composite Units Offering in the amount of $7 million.
Security Name: Units
Security Type: Equity/Derivative Unit
Securities Offered: 116,666,667
Price\Range: $0.06
Security Name: Series B Warrants
Security Type: Equity Warrant
Securities Offered: 233,333,334
Security Name: Pre-Funded Units
Security Type: Equity/Derivative Unit
Securities Offered: 50,035,740 Board Change • Mar 11
Less than half of directors are independent Following the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Carmel Zigdon was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Tillkännagivande • Mar 08
BYND Cannasoft Enterprises Inc., Annual General Meeting, May 08, 2024 BYND Cannasoft Enterprises Inc., Annual General Meeting, May 08, 2024. Tillkännagivande • Feb 13
BYND Cannasoft Enterprises Inc. Appoints Mor Bzizinsky to the Board of Directors BYND Cannasoft Enterprises Inc. announced the appointment of Mor Bzizinsky to its board of directors. Ms. Bzizinsky received a B.A. in Law and Economics from the College of Management in Rishon LeZion, Israel. She has been an attorney since 2012, and owns and manages a private law practice. New Risk • Jan 24
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: CA$12.8m (US$9.47m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$4.4m free cash flow). Shares are highly illiquid. Earnings have declined by 21% per year over the past 5 years. Revenue is less than US$1m (CA$1.1m revenue, or US$820k). Market cap is less than US$10m (CA$12.8m market cap, or US$9.47m). Minor Risk Shareholders have been diluted in the past year (12% increase in shares outstanding). Board Change • Jan 10
High number of new and inexperienced directors There are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. President & Director Moti Maram is the most experienced director on the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Reported Earnings • Nov 17
Third quarter 2023 earnings released: CA$0.037 loss per share (vs CA$0.011 loss in 3Q 2022) Third quarter 2023 results: CA$0.037 loss per share (further deteriorated from CA$0.011 loss in 3Q 2022). Net loss: CA$1.44m (loss widened 342% from 3Q 2022). Reported Earnings • Aug 11
Second quarter 2023 earnings released: CA$0.03 loss per share (vs CA$0.016 loss in 2Q 2022) Second quarter 2023 results: CA$0.03 loss per share (further deteriorated from CA$0.016 loss in 2Q 2022). Net loss: CA$1.15m (loss widened 142% from 2Q 2022). New Risk • Jul 19
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: CA$67.9m (US$51.5m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$4.2m free cash flow). Share price has been highly volatile over the past 3 months (26% average weekly change). Earnings have declined by 18% per year over the past 5 years. Revenue is less than US$1m (CA$1.1m revenue, or US$826k). Minor Risks Shareholders have been diluted in the past year (28% increase in shares outstanding). Market cap is less than US$100m (CA$67.9m market cap, or US$51.5m). Tillkännagivande • Jul 18
BYND Cannasoft Enterprises Inc. has completed a Follow-on Equity Offering in the amount of $2.600001 million. BYND Cannasoft Enterprises Inc. has completed a Follow-on Equity Offering in the amount of $2.600001 million.
Security Name: Common Shares
Security Type: Common Stock
Securities Offered: 1,733,334
Price\Range: $1.5 Tillkännagivande • Jul 11
BYND Cannasoft Enterprises Inc. Announces Successful Completion of Laboratory Testing Phase for EZ-G Device Optimization BYND Cannasoft Enterprises Inc. announced the successful completion of the laboratory testing phase aimed at optimizing the various sensors in its innovative EZ-G device. The EZ-G device, a therapeutic solution utilizing AI and machine learning, has shown promise in releasing low concentrations of CBD oils, including hemp seed oil and other natural oils, to potentially address specific women's health issues. Throughout the laboratory testing phase, the Company conducted comprehensive experiments as part of the prototype development of the EZ-G device. the focus was on assessing the functionality and performance of the assembled sensors within the device, capable of detecting indicators such as temperature, heart rate, contracts, and fluids. By collecting and transferring data to the accompanying software, the information derived from these indicators was processed to optimize the device's usage for the user through machine learning technology. This crucial milestone in the EZ-G device's development demonstrates the successful functionality of its capable sensor, the primary sensor within the device. The sensor has proven its capability to accurately detect the presence or absence of liquid within the device, specifically identifying changes in the fluid volume within the vagina. Consequently, the device can regulate the flow of oil or lubricating fluid during operation without requiring manual intervention from the user. With the positive outcomes achieved during the trial, BYND Cannasoft is now committed to finalizing the EZ-G prototype model and progressing to the next phase of development: human trials involving focus groups of women of different age groups. The Company remains committed to ensuring the EZ-G device meets the highest safety, efficacy, and usability standards. Through continued research and development efforts, BYND Cannasoft aims to contribute to the well-being of women by providing an innovative solution for targeted health concerns. Reported Earnings • May 17
First quarter 2023 earnings released: CA$0.02 loss per share (vs CA$0.006 loss in 1Q 2022) First quarter 2023 results: CA$0.02 loss per share (further deteriorated from CA$0.006 loss in 1Q 2022). Net loss: CA$740.4k (loss widened 348% from 1Q 2022). Board Change • Apr 17
Less than half of directors are independent There are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). President & Director Moti Maram is the most experienced director on the board, commencing their role in 2021. Independent Director Niv Shirazi was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. Tillkännagivande • Jan 18
BYND Cannasoft Enterprises Inc. Files US Provisional Patent Application and Full Scale PCT Application for Its EZ-G Device BYND Cannasoft Enterprises Inc. announced that in addition to the US Provisional Patent Application with serial number 63/297,009 that was filed on January 6, 2022, covering the monitoring and controlling aspects of its EZ-G device, the company filed a full-scale PCT application on January 5, 2023, under serial number PCT/IL2023/050016. The PCT application is based on BYND Cannasoft’s prototype of the EZ-G device that is currently under development and its operational aspects as a learning adult device. The PCT application further claims priority from the US Provisional application and covers an adult device with a structure and one or more moving and vibrating elements. In addition to potentially treating annoying phenomena in the female reproductive system, the EZ-G device includes technological advancements as a sex toy with a more realistic experience. The EZ-G device prototype uses sensors like a pressure sensor, temperature sensor, conductivity sensor, and heart rate sensor to determine what specifically enhances the users' pleasure. The EZ-G device uses artificial intelligence (AI) to transmit and receive data from the device's sensors on conditions of the user's sexual organs, such as moisture levels and pressure variations due to muscle contraction. The EZ-G prototype includes a Bluetooth component for controlling the adult device via an app installed on a smartphone or other portable device to collect user information about preferences and generate custom programs. The data collected from the sensors is uploaded to the secured cloud, where it is combined with other antonymic user's preferences, including the actual duration of operation of the adult device, lubrication level, and the ideal vibration level. This information optimizes the operation of the device to satisfy the user sexually. The EZ-G device uses the collected secured data to learn the users' responses and improve its operation to bring the user sexual satisfaction. Wearable tech has seen tremendous growth in recent years. When most people think of wearables, they think of fitness trackers and smartwatches, but there is also an emerging trend in wearable sex toys. The excitement of a sex toy and the thrill of clandestine public stimulation have contributed to this trend. Cannasoft intends to take advantage of the growth in the sextech market, which is expected to reach $62.32 by 2030. According to Forbes, companies are working to innovate products that have an intelligent response for sexual activity to take advantage of this expected growth. Board Change • Jan 09
Less than half of directors are independent There are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). President & Director Moti Maram is the most experienced director on the board, commencing their role in 2021. Independent Director Niv Shirazi was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. Tillkännagivande • Dec 08
BYND Cannasoft Enterprises Inc. Announces the Advanced Stages of Expanding Its EZ-G Device's Applications into the Leisure Field of Sex Toys BYND Cannasoft Enterprises Inc. announced it is in the advanced stages of expanding its EZ-G device's applications into the leisure field of sex toys. In addition to potentially treating annoying phenomena in the female reproductive system, the EZ-G device includes technological advancements as a sex toy with a more realistic experience. The global sex toys market size is expected to reach USD 62.32 billion by 2030 and is projected to register a CAGR of 8.4%, according to international research organization ResearchAndMarkets.com. In addition to use by women, adult toys are being used more frequently by couples who enjoy them, which is one factor expected to drive future growth in the industry. In recent years, many customers began using app-enabled sex toys and Bluetooth-powered toys to reduce the risk of exposure to harmful chemicals. BYND Cannasoft will utilize the knowledge and technology of the patent application it recently filed to create various products, some of which will be combined with CBD oils at low concentrations or some other non-drug oils to increase pleasure in intimate relationships. Board Change • Nov 16
Less than half of directors are independent There are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). President & Director Moti Maram is the most experienced director on the board, commencing their role in 2021. Independent Director Niv Shirazi was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. Reported Earnings • Nov 12
Third quarter 2022 earnings released: CA$0.011 loss per share (vs CA$0.002 loss in 3Q 2021) Third quarter 2022 results: CA$0.011 loss per share (further deteriorated from CA$0.002 loss in 3Q 2021). Net loss: CA$325.8k (loss widened 450% from 3Q 2021). Tillkännagivande • Nov 05
BYND Cannasoft Enterprises Inc. Provides Update on International Patent Application Process for Its Revolutionary EZ-G Device BYND Cannasoft Enterprises Inc. announced that as part of the PCT patent application process for the EZ-G device, an International Searching Authority ("ISA") examiner has provided a preliminary, non-binding opinion that one of the inventions comprising the EZ-G device is novel and inventive. BYND Cannasoft can now accelerate the examination of its present application in some jurisdictions, such as the US and Israel, as part of a PCT-PPH program. Although non-binding, the positive opinion of the ISA examiner provides greater comfort of the patent application proceeding through the examination procedure without objections being raised as to a substantive lack of patentability. The EZ-G device is a unique, patent-pending device that, combined with proprietary software (provisional application), regulates the flow of low-concentration CBD oils into the soft tissues of the female reproductive system. According to research conducted across the globe, treatment with low-concentration CBD oils can relieve candida, dryness, scars, and many other female health issues. The Patent Prosecution Highway (PPH) is an examination cooperation program between two patent offices that allows the applicant to request accelerated examination to the second office if a corresponding application has been found allowable and patentable by the first office. The PPH works in conjunction with the PCT. This coordination allows applicants to obtain patents worldwide and build a global portfolio quickly. Tillkännagivande • Oct 19
BYND Cannasoft Enterprises Inc. Receives Initial Approval to Engage in Medical Cannabis Without Direct Contact BYND Cannasoft Enterprises Inc. announced that it received initial approval to engage in medical cannabis without direct contact with the substance from the Medical Cannabis Unit at the Ministry of Health of the State of Israel. Cannasoft received this initial approval as part of the process to obtain a full license that allows trading in medical cannabis products through an agreement with a licensed cannabis grower in Israel. Cannasoft is in the final stage of obtaining the full license. The standardization of the medical cannabis field in Israel is among the first in the world. It is an innovative and original process utilizing considerable efforts to provide medical care according to a regulated medical method and practice. The Medical Cannabis Unit at the Ministry of Health of the State of Israel has set high standards in the field of medical cannabis in Israel to shorten waiting times and makes the service and procurement of cannabis products accessible to patients. Upon receipt of the full license, Cannasoft intends to immediately implement and execute an agreement with a licensed Israeli grower to produce and distribute various medical cannabis products that constitute the Company's private brand for all pharmacies and pharmacy chains in Israel. The Company has a penetration strategy for the medical cannabis products market in Israel, which currently has about 150,000 users with an annual sales volume of about half a billion dollars. BYND Cannasoft intends to capture a market share of about 3%, worth about $15 million in sales, within a year of putting its products on store shelves. The Company has completed several additional requirements of the Medical Cannabis Unit in recent months. Receiving this initial approval, along with the completion of these additional requirements, brought the Company closer to obtaining the full license. Tillkännagivande • Oct 07
BYND Cannasoft Enterprises Inc. announced that it has received CAD 0.61657 million in funding On October 6, 2022, BYND Cannasoft Enterprises Inc. closed the transaction. The company issued 142,395 common shares at an issue price of CAD 4.33 per share, raising CAD 616,570. The securities issued will be subject to a hold period that expires on February 6, 2023. No finders fees were paid in the transaction. Tillkännagivande • Oct 01
BYND Cannasoft Enterprises Inc. announced that it expects to receive CAD 0.6495 million in funding BYND Cannasoft Enterprises Inc. announced a non-brokered private placement to issue up to 150,000 common shares at an issue price of CAD 4.33 per share for gross proceeds of CAD 649,500 on September 30 2022. The transaction is scheduled to close prior to the end of October and is conditional upon receipt of all necessary regulatory approvals. No finder’s fee will be payable in connection with the Private Placement. Pursuant to Canadian securities laws, all common shares which are issued pursuant to the Private Placement, will be subject to a hold period of four months plus one day from the date of closing of the Private Placement. The common shares are expected to be offered to investors located in Israel only. No securities will be offered or sold in the United States or to U.S. investors. Tillkännagivande • Sep 24
BYND Cannasoft Enterprises Inc. (CNSX:BYND) completed the acquisition of Zigi Carmel Initiatives & Investments Ltd from Carmel Zigdon. BYND Cannasoft Enterprises Inc. (CNSX:BYND) signed a share purchase agreement to acquire Zigi Carmel Initiatives & Investments Ltd. for $34.6 million from Carmel Zigdon on September 19, 2022. Under the terms, BYND will issue 7.92 million shares as part of the consideration and will pay $0.1 million to Carmel Zigdon for legal costs in connection with the transaction and will elect Carmel Zigdo to BYND Cannasoft’s Board of Directors. The closing of the transaction is subject to certain customary conditions and is expected to close on September 22, 2022. These shares are subject to a hold period and may not be traded in Canada before January 23, 2023. The Company also reports that Carmel has been appointed as a director of BYND.
BYND Cannasoft Enterprises Inc. (CNSX:BYND) completed the acquisition of Zigi Carmel Initiatives & Investments Ltd from Carmel Zigdon on September 22, 2022. Tillkännagivande • Sep 19
BYND Cannasoft Enterprises Inc. (CNSX:BYND) signed a share purchase agreement to acquire Zigi Carmel Initiatives & Investments Ltd. BYND Cannasoft Enterprises Inc. (CNSX:BYND) signed a share purchase agreement to acquire Zigi Carmel Initiatives & Investments Ltd. on September 19, 2022. Under the terms, BYND will issue 7.92 million as part of the consideration. The closing of the transaction is subject to certain customary conditions and is expected to close in the month of September. Reported Earnings • Aug 14
Second quarter 2022 earnings released: CA$0.016 loss per share (vs CA$0.006 loss in 2Q 2021) Second quarter 2022 results: CA$0.016 loss per share (down from CA$0.006 loss in 2Q 2021). Revenue: CA$207.7k (down 50% from 2Q 2021). Net loss: CA$473.4k (loss widened 374% from 2Q 2021). Reported Earnings • Jun 01
First quarter 2022 earnings released: CA$0.006 loss per share (vs CA$0.52 loss in 1Q 2021) First quarter 2022 results: CA$0.006 loss per share (up from CA$0.52 loss in 1Q 2021). Revenue: CA$455.3k (up 87% from 1Q 2021). Net loss: CA$165.3k (loss narrowed 96% from 1Q 2021). Board Change • Jun 01
Less than half of directors are independent There are 7 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 7 new directors. No experienced directors. No highly experienced directors. 3 independent directors (4 non-independent directors). President & Director Moti Maram is the most experienced director on the board, commencing their role in 2021. Independent Director Niv Shirazi was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. Tillkännagivande • Apr 09
BYND Cannasoft Enterprises Inc., Annual General Meeting, Jun 07, 2022 BYND Cannasoft Enterprises Inc., Annual General Meeting, Jun 07, 2022. Tillkännagivande • Mar 10
BYND Cannasoft Enterprises Inc. Announces Management Changes BYND Cannasoft Enterprises Inc. announced the appointment of Niv Shirazi to its board of directors. Since 2018, Mr. Shirazi has served as Chief Operating Officer for H.N. Win Ltd., an Israeli real estate firm. The Company also announced that Mr. Shirazi has been appointed to the Company's audit committee in place of Gabi Kabazo, BYND's CFO. As a result of Mr. Shirazi's appointment, the Company's audit committee is now comprised entirely of independent directors. Tillkännagivande • Jan 14
BYND Cannasoft Enterprises Inc. announced that it has received CAD 0.122949 million in funding On January 13, 2022, BYND Cannasoft Enterprises Inc. closed the transaction. In connection with the financing, the company issued 40,983 common shares to a single investor at an issue price of CAD 3.00 per share, raising CAD 122,950 of gross proceeds. The common shares issued in connection with the financing are subject to a statutory hold period under applicable securities laws, which expires on May 14, 2022. No finders fees were paid in connection with the financing. Tillkännagivande • Dec 17
BYND Cannasoft Enterprises Inc. announced that it expects to receive CAD 0.122949 million in funding BYND Cannasoft Enterprises Inc. announced a non-brokered private placement to issue 40,983 common shares at an issue price of CAD 3 per share for gross proceeds of CAD 122,950 on December 16, 2021. The private placement is scheduled to close prior to the end of December and is conditional upon receipt of all necessary regulatory approvals. No finder's fee will be payable in connection with the private placement. pursuant to canadian securities laws, all common shares which are issued pursuant to the private placement, will be subject to a hold period of four months plus one day from the date of closing of the private placement. Tillkännagivande • Jul 07
BYND Cannasoft Enterprises Inc. announced that it has received CAD 1.84 million in funding On July 5, 2021, BYND Cannasoft Enterprises Inc. closed the transaction. The securities issued in connection with the financing are subject to a statutory hold period under applicable securities laws, which expires on November 6, 2021. No finders fees were paid in connection with the financing. Tillkännagivande • Jun 22
BYND Cannasoft Enterprises Inc. announced that it expects to receive CAD 1.84 million in funding BYND Cannasoft Enterprises Inc. (CNSX:BYND) announced a non-brokered private placement of up to 2,000,000 shares at an issue price of CAD 0.92 per share for gross proceeds of up to CAD 1,840,000 on June 21, 2021. The transaction scheduled to close prior to the end of June or shortly thereafter and is conditional upon receipt of all necessary regulatory approval. The company may finder's fee of up to 10% of the gross proceeds in connection with the transaction. The securities to be issued will be subject to a hold period of four months plus one day from the date of closing of the transaction. Tillkännagivande • May 06
BYND Cannasoft Enterprises Inc. announced that it has received CAD 0.522404 million in funding On May 5, 2021, BYND Cannasoft Enterprises Inc. (CNSX:BYND) closed the transaction. The company has issued 435,337 common shares for the gross proceeds of CAD 522,404.4. Tillkännagivande • Apr 28
BYND Cannasoft Enterprises Inc. announced that it expects to receive CAD 0.5 million in funding BYND Cannasoft Enterprises Inc. (CNSX:BYND) announced a non-brokered private placement of up to 416,667 shares at an issue price of CAD 1.20 per share for gross proceeds of CAD 500,000 on April 26, 2021. The transaction scheduled to close prior to the end of April or shortly thereafter and is conditional upon receipt of all necessary regulatory approval. No finder's fee will be payable in connection with the transaction. The securities to be issued will be subject to a hold period of four months plus one day from the date of closing of the transaction.